Press "Enter" to skip to content

Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules

Drug major Aurobindo Pharma on Friday said it has received final approval from the US health regulator to manufacture and market Droxidopa capsules, used to treat dizziness and lightheadedness. The approved product is a generic version of Lundbeck NA Ltd’s Northera capsules.

Original source:

Also Read:   J&J shares nosedive on report it knew of asbestos in Baby Powder